Loading...
Loading...
India's tofacitinib imports from CHINA total $5.4K across 12 shipments from 4 foreign suppliers. TIANJIN APOCALYPSE TRADING COMPANY leads with $3.3K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for tofacitinib โ a diversified sourcing base with multiple active suppliers from CHINA.

TIANJIN APOCALYPSE TRADING COMPANY is the leading Tofacitinib supplier from CHINA to India, with import value of $3.3K across 2 shipments. The top 5 suppliers โ TIANJIN APOCALYPSE TRADING COMPANY, NOVAST LABORATORIES LTD., M/S. TRIASTEK, INC, ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TIANJIN APOCALYPSE TRADING COMPANY | $3.3K | 2 | 60.4% |
| 2 |
| NOVAST LABORATORIES LTD. |
| $1.8K |
| 6 |
| 33.3% |
| 3 | M/S. TRIASTEK, INC | $327 | 3 | 6.0% |
| 4 | ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. | $12 | 1 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $3.3K | 2 | 60.4% |
| 2 | CITUS RESEARCH LLP | $1.8K | 6 | 33.3% |
| 3 | QPS BIOSERVE INDIA PRIVATE LIMITED | $327 | 3 | 6.0% |
| 4 | ACTIMUS BIOSCIENCES PRIVATE LIMITED | $12 | 1 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tofacitinib suppliers from CHINA to India include TIANJIN APOCALYPSE TRADING COMPANY, NOVAST LABORATORIES LTD., M/S. TRIASTEK, INC. The leading supplier is TIANJIN APOCALYPSE TRADING COMPANY with import value of $3.3K USD across 2 shipments. India imported Tofacitinib worth $5.4K USD from CHINA in total across 12 shipments.
India imported Tofacitinib worth $5.4K USD from CHINA across 12 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tofacitinib sourced from CHINA include AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, CITUS RESEARCH LLP, QPS BIOSERVE INDIA PRIVATE LIMITED. The largest buyer is AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED with $3.3K in imports across 2 shipments.
The total value of Tofacitinib imports from CHINA to India is $5.4K USD, across 12 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
4 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists